Flowchart of the BCs included into this study. by Lucas Romann (14803595)

“…<div><p>Background</p><p>Blood cultures (BC) are critical for the diagnosis of bloodstream infections, pathogen identification, and resistance testing. Guidelines recommend a blood volume of 8–10 mL per bottle as lower volumes result in decreased sensitivity. …”

Calibration results for model proposed in literature [8]. by Xiaocheng Gao (19812705)

Mechanical properties of <i>G</i>. <i>vaginalis</i> colonized cervices. by Luz-Jeannette Sierra (134129)

Dataset and R script. by Joseph Larmarange (361177)

“…We conducted a pooled analysis across the four UTT trials. Leveraging data from 105 communities in five countries, we evaluated the linear relationship between i) population-level viremia (prevalence of non-suppression–defined as plasma HIV RNA >500 or >400 copies/mL–among all adults, irrespective of HIV status) and HIV incidence; and ii) prevalence of non-suppression among PLHIV and HIV incidence, using parametric g-computation. …”

Comparison of the effect of the model in this paper with the model in literature [8] (cross angle is 135 degrees). by Xiaocheng Gao (19812705)

Comparison of the effect of the model in this paper with the model in literature [8] (cross angle is 45 degrees). by Xiaocheng Gao (19812705)

Comparison of the effect of the model in this paper with the model in literature [8] (cross angle is 90 degrees). by Xiaocheng Gao (19812705)

Relationship between the prevalence of non-suppression (among PLHIV) and HIV incidence, by trial. by Joseph Larmarange (361177)

Supplementary Material for: Phosphodiesterase-5 Inhibitors and Dementia Risk: A Real-World Study by Gronich N. (18892231)

“…The second cohort of 133,336 patients with erectile dysfunction included new-users and non-users of any PDE5i.In a mean follow-up of 7.9 years, 8,631 patients were newly diagnosed with dementia. …”

Simplified causal diagram (directed acyclic graph) for the effect of prevalence of non-suppression among PLHIV on HIV incidence. by Joseph Larmarange (361177)

Relationship at community-level between population-level viremia (the proportion of all adults in the community, both HIV+ and HIV-, with non-suppressed plasma HIV RNA level) and H... by Joseph Larmarange (361177)

Relationship at community-level between population-level viremia (the proportion of all adults in the community, both HIV+ and HIV-, with non-suppressed plasma HIV RNA level) and H... by Joseph Larmarange (361177)

Cross-gendered relationship at community-level between population-level viremia (the proportion of all adults in the community, both HIV+ and HIV-, with detectable HIV RNA), and HI... by Joseph Larmarange (361177)

Relationship at community-level between population-level viremia (the proportion of all adults in the community, both HIV+ and HIV-, with non-suppressed plasma HIV RNA level) and H... by Joseph Larmarange (361177)

The temporal dynamics of amino acid changes in the ORF1ab gene associated with changes in viral copies. by Ke Li (106849)

The temporal dynamics of amino acid changes in the S gene associated with changes in viral copies. by Ke Li (106849)

Primer sequences for qPCR. by Erika J. Gruber (11846156)

HAM solutions convergence at various approximation order. by Siva Sankari (2827295)

Relationship between observed population-level viremia and HIV incidence, by trial and by sex. by Joseph Larmarange (361177)

Trial key features, HIV prevalence at baseline, prevalence of non-suppression among PLHIV at baseline, and observed overall HIV incidence, by trial and arm. by Joseph Larmarange (361177)